In fact, there is evidence that the expression of the receptor by itself is sufficient to promote growth and invasion of tumor xenografts in nude mice and that knocking down PAR‐1 gene expression impaired the mobility of invasive breast cancer cells. This evidence concerns the gene F2R and breast cancer.